Tumor cells escape suicide gene therapy by genetic and epigenetic instability.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Blood

• Publication date

  2004-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD-2004-03-0852PMID 15308565
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RTCGD: retroviral tagged cancer gene database

  2004cited by this paper
• Suicide gene therapy mediated by the Herpes Simplex virus thymidine kinase gene/Ganciclovir system: fifteen years of application.

  2003cited by this paper
• Transcription Start Regions in the Human Genome Are Favored Targets for MLV Integration

  2003cited by this paper
• Development and application of quantitative real time PCR and RT-PCR assays that discriminate between the full-length and truncated herpes simplex virus thymidine kinase gene.

  2003cited by this paper
• Side effects of retroviral gene transfer into hematopoietic stem cells.

  2003cited by this paper
• LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1

  2003cited by this paper
• DNA methylation in cancer: too much, but also too little

  2002cited by this paper
• Influence of the bystander effect on HSV-tk/GCV gene therapy. A review.

  2002cited by this paper
• Murine Leukemia Induced by Retroviral Gene Marking

  2002cited by this paper
• Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours

  2002cited by this paper
• Targeting tumors with non-viral gene delivery systems.

  2002cited by this paper
• HIV-1-derived lentiviral vectors.

  2002cited by this paper
• Abschaltungsmechanismen retroviraler Gensequenzen : Konstruktion verbesserter Vektoren für die somatische Gentherapie beim Menschen

  2002cited by this paper
• Detection and Direct Genomic Sequencing of Multiple Rare Unknown Flanking DNA in Highly Complex Samples

  2001cited by this paper
• Two genetic hits (more or less) to cancer

  2001cited by this paper
• Non-viral vectors in cancer gene therapy: principles and progress

  2001cited by this paper
• Nonviral Vectors in the New Millennium: Delivery Barriers in Gene Transfer

  2001cited by this paper
• Repeat expansion by homologous recombination in the mouse germ line at palindromic sequences

  2001cited by this paper
• Developments in suicide genes for preclinical and clinical applications.

  2000cited by this paper
• Immune response to green fluorescent protein: implications for gene therapy

  1999cited by this paper
• Genetic instabilities in human cancers

  1998cited by this paper
• FMEV vectors: both retroviral long terminal repeat and leader are important for high expression in transduced hematopoietic cells

  1998cited by this paper
• Double Suicide Gene (Cytosine Deaminase and Herpes Simplex Virus Thymidine Kinase) but Not Single Gene Transfer Allows Reliable Elimination of Tumor Cells In Vivo

  1998cited by this paper
• Limitations of Retrovirus-Mediated HSV-tk Gene Transfer to Pulmonary Adenocarcinoma Cells In Vitro and In Vivo

  1997cited by this paper
• J. Virol. Methods

  1996cited by this paper
• Metabolic suicide genes in gene therapy.

  1994cited by this paper
• Drug sensitivity ("suicide") genes for selective cancer chemotherapy.

  1994cited by this paper
• Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component.

  1994cited by this paper
• Drug sensitivity ("suicide") genes for selective cancer chemotherapy.

  1994cited by this paper
• Herpes simplex-1 virus thymidine kinase gene is unable to completely eliminate live, nonimmunogenic tumor cell vaccines.

  1992cited by this paper
• Applications of the Polymerase Chain Reaction in Retroviral-Mediated Gene Transfer and the Analysis of Gene-Marked Human TIL Cells

  1990cited by this paper
• Role of endogenous retroviruses as mutagens: the hairless mutation of mice.

  1988cited by this paper
• Excision of the DBA ecotropic provirus in dilute coat-color revertants of mice occurs by homologous recombination involving the viral LTRs.

  1983cited by this paper

• Gene Therapy with Gene Delivery Systems and Therapeutic Strategies: A New Frontier in Cancer Treatment

  2025cites this paper
• Metabolic engineering generates a transgene-free safety switch for cell therapy

  2020cites this paper
• Metabolic engineering generates a transgene-free safety switch for cell therapy

  2020cites this paper
• Targeted Delivery of Secretory Promelittin via Novel Poly(lactone‐co‐β‐amino ester) Nanoparticles for Treatment of Breast Cancer Brain Metastases

  2020cites this paper
• Gene Therapy in Skeletal Muscle Repair and Regeneration

  2018cites this paper
• Synthetic Immunology: Hacking Immune Cells to Expand Their Therapeutic Capabilities.

  2017cites this paper
• Long-term treatment with valganciclovir improves lentiviral suicide gene therapy of glioblastoma.

  2017cites this paper
• Escape Mutations, Ganciclovir Resistance, and Teratoma Formation in Human iPSCs Expressing an HSVtk Suicide Gene

  2016cites this paper
• Chimeric antigen receptor-modified T cells for the treatment of solid tumors: Defining the challenges and next steps.

  2016cites this paper
• Retroviral Vectors for Cancer Gene Therapy.

  2016cites this paper
• Conditional control of suicide gene expression in tumor cells with theophylline-responsive ribozyme

  2016cites this paper
• Therapeutic targeting of naturally presented myeloperoxidase-derived HLA peptide ligands on myeloid leukemia cells by TCR-transgenic T cells

  2014cites this paper
• Development of liver suction-mediated naked plasmid DNA delivery system for in vivo gene therapy

  2014cites this paper
• Clinical application of genetically modified T cells in cancer therapy

  2014cites this paper
• T Cells Bearing a Chimeric Antigen Receptor Against the Tumor Vasculature Destroy the Tumor Endothelium and Result in Tumor Regression

  2014cites this paper
• Plasmid Transgene Expression in vivo: Promoter and Tissue Variables

  2013cites this paper
• ATRA resistance in AML patients MN1 overexpression induces acute myeloid leukemia in mice and predicts

  2013cites this paper
• Micro/Nanospheres for Gene Drug Delivery

  2013cites this paper
• Conditional negative selection of gene-modified hematopoietic stem cells.

  2012cites this paper
• AAV vectors for the nucleolus.

  2012cites this paper
• Safeguarding pluripotent stem cells for cell therapy with a non-viral, non-integrating episomal suicide construct.

  2012cites this paper
• Dominant-Negative Androgen Receptor Inhibition of Intracrine Androgen-Dependent Growth of Castration-Recurrent Prostate Cancer

  2012cites this paper
• Challenges in T cell receptor gene therapy

  2012cites this paper
• Thymidine kinase suicide gene-mediated ganciclovir ablation of autologous gene-modified rhesus hematopoiesis.

  2012cites this paper
• PET imaging for gene & cell therapy.

  2012cites this paper
• Cell fate control gene therapy based on engineered variants of human deoxycytidine kinase.

  2012cites this paper
• Safety analysis of TCR gene-modified T cells

  2012cites this paper
• Development of Novel Cell Fate Control Gene Therapy for Applications in Cancer and Immune Disorders

  2012cites this paper
• Stem cell gene therapy: the risks of insertional mutagenesis and approaches to minimize genotoxicity

  2011cites this paper
• Functional p53 is required for effective execution of telomerase inhibition in BCR-ABL-positive CML cells.

  2011cites this paper
• Genetic surgery - a right strategy to attack cancer.

  2011cites this paper
• Cancer suicide gene therapy with TK.007: superior killing efficiency and bystander effect

  2011cites this paper
• Development of lentiviral vectors to study the influence of angiogenic molecules on glioma growth

  2010cites this paper
• Generation and genetic modification of induced pluripotent stem cells

  2010cites this paper
• Enhanced T cell receptor gene therapy for cancer

  2010cites this paper
• The down regulation of target genes by photo activated DNA nanoscissors.

  2010cites this paper
• Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease

  2010cites this paper
• Ex vivo liver-directed gene therapy for the treatment of metabolic diseases: advances in hepatocyte transplantation and retroviral vectors.

  2009cites this paper
• Tumor-associated macrophages as targets for tumor immunotherapy.

  2009cites this paper
• TCR transgenes and transgene cassettes for TCR gene therapy: status in 2008

  2009cites this paper
• Not gene therapy, but genetic surgery—the right strategy to attack cancer

  2009cites this paper
• Current state of myocardial tissue engineering.

  2009cites this paper
• Quantitative analysis of clinically relevant mutations occurring in lymphoid cells harboring γ-retrovirus-encoded hsvtk suicide genes

  2008cites this paper
• Establishment of immortalized multipotent hematopoietic progenitor cell lines by retroviral-mediated gene transfer of beta-catenin.

  2008cites this paper
• A new safeguard eliminates T cell receptor gene-modified auto-reactive T cells after adoptive therapy

  2008cites this paper
• A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer

  2008cites this paper
• Exonuclease-1 deletion impairs DNA damage signaling and prolongs lifespan of telomere-dysfunctional mice.

  2007cites this paper
• MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in AML patients

  2007cites this paper
• Effective suicide gene therapy for leukemia in a model of insertional oncogenesis in mice.

  2007cites this paper
• I could die for you: new prospects for suicide in gene therapy.

  2007cites this paper
• MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML.

  2007cites this paper
• Redirecting T lymphocyte specificity by T cell receptor gene transfer--a new era for immunotherapy.

  2007cites this paper
• New Bioinformatic Strategies to Rapidly Characterize Retroviral Integration Sites of Gene Therapy Vectors

  2007cites this paper
• Remarkable leukemogenic potency and quality of a constitutively active neurotrophin receptor, ΔTrkA

  2007cites this paper
• Lentiviral and Retroviral Vector Systems

  2007cites this paper
• Importance of murine study design for testing toxicity of retroviral vectors in support of phase I trials.

  2007cites this paper
• Genetic modification of T cells for immunotherapy

  2007cites this paper
• Remarkable leukemogenic potency and quality of a constitutively active neurotrophin receptor, deltaTrkA.

  2007cites this paper
• Application of HSVtk suicide gene to X-SCID gene therapy: ganciclovir treatment offsets gene corrected X-SCID B cells.

  2006cites this paper
• Genotoxicity of retroviral integration in hematopoietic cells.

  2006cites this paper
• From the Department of Medicine Karolinska Institutet GENETIC MODIFICATION OF HUMAN NATURAL KILLER CELLS

  2006cites this paper
• Retroviral vector insertions in T-lymphocytes used for suicide gene therapy occur in gene groups with specific molecular functions

  2006cites this paper
• Therapeutic potential of natural killer cells in multiple myeloma

  2006cites this paper
• The CD20/αCD20 ‘suicide’ system: novel vectors with improved safety and expression profiles and efficient elimination of CD20-transgenic T cells

  2006cites this paper
• Spectral karyotyping of human, mouse, rat and ape chromosomes – applications for genetic diagnostics and research

  2006cites this paper
• AIMP3 haploinsufficiency disrupts oncogene-induced p53 activation and genomic stability.

  2006cites this paper
• Gene therapy for cancer treatment: past, present and future.

  2006cites this paper
• Cytogenetic characteristics of a murine in vitro model for the human anaplastic large cell lymphoma (ALCL)

  2006cites this paper
• Oncogene-induced senescence as an initial barrier in lymphoma development

  2005cites this paper
• Human Endogenous Retrovirus Expression Profiles in Samples from Brains of Patients with Schizophrenia and Bipolar Disorders

  2005cites this paper
• Engineering Myocardial Tissue

  2005cites this paper
• Evidence for increased risk of secondary graft failure after in vivo depletion of suicide gene-modified T lymphocytes transplanted in conjunction with CD34+-enriched blood stem cells.

  2004cites this paper